A Notice of Intent to appoint an administrator was published last month
Maria Eagle MP held an urgent meeting with TriRx Pharmaceutical Services last week after the company announced its intention to appoint administrators. The self-proclaimed “leading player” in the pharmaceutical industry issued a Notice of Intent to appoint an administrator, with the Garston MP now confirming 450 jobs are at risk should the company enter into administration.
The company, which has facilities in Alabama and Kansas in America, Segre in France as well as on Fleming Road in Speke, confirmed to the ECHO it has taken the decision to file the notice based on the “current situation with its core customer” one week ago. Ms Eagle, who is Minister for Defence, told the ECHO: “On Friday (September 6) I met with site management at TriRX who confirmed a notice of administration had been served for ten days time, 16 September.
“There are ongoing discussions between TriRX and Elanco to see if there is a solution that will save the site and save jobs. Discussions are also ongoing with TriRX in the US. I am writing to the corporate centre of Eli Lilly to see if they can keep the plant operational.
READ MORE: ‘Pack of animals’ call judge a ‘nonce’ as they’re jailed for nearly 50 yearsREAD MORE: After her ‘beautiful’ son died and the ‘system failed’ him, a mum knew what she had to do
“I’ll also be talking to the Office of Life Sciences and the Department of Science and Technology to see what else can be done. I’m hoping to speak to trade union representatives of impacted staff this week.”
We use your sign-up to provide content in ways you’ve consented to and improve our understanding of you. This may include adverts from us and third parties based on our knowledge of you. More info
Approached for confirmation about the Notice of Intent, Nick Davis, site director of the Speke facility, said: “TriRx Pharmaceuticals, a leading player in the pharmaceutical contract manufacturing and development space, have issued a Notice of Intent to appoint an administrator at their site located in Speke, Liverpool.
“As of Friday 30 August, the directors of TriRx Speke took the decision that, based on the current situation with its core customer, they had no choice but to file a Notice of Intention to appoint an administrator. The company is not in administration at this point in time, and the directors are working hard to secure a solution for the site.”
Administration is the process where a licensed insolvency practitioner is appointed to oversee and protect a business or limited company. The Notice of Intent is a document filed to a court that states a company’s intentions to enter administration in an attempt to save it from liquidation, with 10 business days to prevent the company going into administration.
TriRx’s facilities in Speke provide drug substance services to “help develop and manufacture” pharmaceutical ingredients. The company’s website said about the site: “Services available include process development and production, non-sterile liquid filling, fermentation, spray drying, coating, pre-mixing, and Speke also has an on-site analytical laboratory for extensive quality control (QC) and stability testing.” The ECHO has approached Eli Lilly for comment.
